Predictors Associated With Stroke or Systemic Embolism in Atrial Fibrillation Patients With a CHA2DS2-VA Score of 0 or 1

Recruiting

Phase N/A Results N/A

Summary of Purpose

The purposes of this study are to assess the prevalence of patients with a low risk of stroke or systemic embolism based on a CHA2DS2-VASc score among patients who have an AF-related thromboembolism and to identify the clinical and genetic factors associated with thromboembolism in AF patients with a CHA2DS2-VA score of 0 or 1.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 October 2017.

6 Apr 2017 6 May 2017 1 Apr 2018 1 Apr 2019 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts